home / stock / bcda / bcda news

BCDA News and Press, BioCardia Inc.

Stock Information
Company Name: BioCardia Inc.
Stock Symbol: BCDA
Market: NASDAQ
Website: biocardia.com
Menu
BCDA BCDA Quote BCDA Short BCDA News BCDA Articles BCDA Message Board
Get BCDA Alerts

News, Short Squeeze, Breakout and More Instantly...
BCDA - BioCardia Completes FDA Pre-Submission for Helix Transendocardial Delivery Catheter

2026-02-10 10:31:15 ET BioCardia, Inc. (Nasdaq: BCDA) , a developer of cellular and cell-derived therapies for cardiovascular and pulmonary diseases, has taken an important regulatory step forward. Specifically, the company announced it has completed a Pre-Submission to the U.S. Food an...
BCDA - BioCardia Files Pre-Submission for FDA Approval of Helix(TM) Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart

SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc.  [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported it has completed its Pre-Submission to FDA under its Q-Submission program fo...

BCDA - BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)

SUNNYVALE, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced echocardiography data for the CardiAMP Cell Therapy for the treatment of...

BCDA - BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary clinical consultation with Japan&#...
BCDA - BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno

SUNNYVALE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA] , a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the election of Mr. Marvin Slosman to its Board of Directors, effect...

BCDA - BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress

SUNNYVALE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA] , a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces it will participate at the CSI Focus Devices in Heart Failure this w...

BCDA - BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA] , a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces the appointment of Farhan Shahab as Vice President of Quality. Mr. S...
BCDA - BioCardia anticipates Japan PMDA review and FDA meeting request on CardiAMP in Q4 2025 while advancing clinical programs

2025-11-13 00:12:19 ET More on BioCardia BioCardia, Inc. (BCDA) Q3 2025 Earnings Call Transcript BioCardia GAAP EPS of -$0.24 misses by $0.01 BioCardia announces pricing of up to $12M public offering Seeking Alpha’s Quant Rating on BioCardia Hi...

BCDA - BioCardia, Inc. (BCDA) Q3 2025 Earnings Call Transcript

2025-11-13 00:11:34 ET BioCardia, Inc. (BCDA) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Miranda Peto Benvenuti Peter Altman - CEO, President & Director David McClung - Chief Financial Officer ... Read the full article on...

BCDA - BioCardia GAAP EPS of -$0.24 misses by $0.01

2025-11-12 16:54:50 ET More on BioCardia BioCardia announces pricing of up to $12M public offering Seeking Alpha’s Quant Rating on BioCardia Historical earnings data for BioCardia Financial information for BioCardia Read the full article on S...
Next 10